Target structures for HIV-1 inactivation by methylene blue and light

Area of Science:

• Virology
• Biochemistry
• Photochemistry

Background:

• Photodynamic inactivation is a method for pathogen reduction in blood products.
• Methylene blue (MB) is a photosensitizer used in virus inactivation.
• Human Immunodeficiency Virus-1 (HIV-1) is a significant concern for blood safety.

Purpose of the Study:

• To elucidate the mechanism of photodynamic inactivation of HIV-1 using methylene blue and visible light.
• To investigate the effects of methylene blue/light treatment on key HIV-1 components: reverse transcriptase (RT), p24 protein, gp120, and viral RNA.

Main Methods:

• Recombinant reverse transcriptase (RT) activity assays in the presence and absence of light and methylene blue.
• Western blotting to detect alterations in HIV-1 p24 and gp120 proteins.
• Polymerase Chain Reaction (PCR) inhibition assays to assess viral RNA integrity.

Main Results:

• Methylene blue alone did not inhibit RT activity in the dark.
• Photoinactivation with methylene blue and light dose-dependently inactivated recombinant RT.
• Western blotting revealed alterations in HIV-1 p24 and gp120, suggesting protein cross-linking.
• PCR inhibition assays indicated destruction of viral RNA following treatment.
• RT activity was significantly inhibited after photoinactivation of whole HIV-1 virions.

Conclusions:

• Methylene blue/light treatment effectively inactivates HIV-1 through multiple mechanisms.
• The treatment targets viral envelope and core proteins, as well as internal RNA and RT.
• This photodynamic approach demonstrates potential for robust HIV-1 inactivation in plasma.